Cardiac Outcomes after Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance without Diabetes

BACKGROUND: Insulin resistance is highly prevalent among patients with atherosclerosis and is associated with an increased risk for myocardial infarction (MI) and stroke. The Insulin Resistance Intervention after Stroke (IRIS) trial demonstrated that pioglitazone decreased the composite risk for fat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Circulation
Päätekijät: Young, Lawrence H., Viscoli, Catherine M., Curtis, Jeptha P., Inzucchi, Silvio E., Schwartz, Gregory G., Lovejoy, Anne M., Furie, Karen L., Gorman, Mark J., Conwit, Robin, Abbott, J. Dawn, Jacoby, Daniel L., Kolansky, Daniel M., Pfau, Steven E., Ling, Frederick S., Kernan, Walter N.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5511545/
https://ncbi.nlm.nih.gov/pubmed/28246237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.116.024863
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia